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Colon cancer arises fro m mucosal co lonic polyps. Co lon cancer commonly known as bowel cancer, is a cancer caused by uncontrolled cell growth (neoplasia), in the colon, rectum, or vermiform appendix. Colorectal cancers start in the lining of the bowel. It can grow into the muscle layers underneath and then through the bowel wall (If left untreated).
Curcu min is the principal curcu minoid of the popular Indian spice turmeric, which is a member o f the ginger family (Zingiberaceae). The curcuminoids are polyphenols and are responsible for the yellow co lor of turmeric. 2 Curcu min is a potential anticancer drug it show its effect through Molecular Targets in Colon Cancer. Accumulat ing evidence suggests that curcumin has a diverse range of mo lecular targets. This polyphenol modulates various targets through direct interaction or modulat ion of gene expression. Curcu min physically binds to as many as 33 different proteins, including thioredoxin reductase, cyclooxygenase-2 (COX-2), protein kinase C (PKC), 5-lipo xygenase (5-LOX), and tubulin. Molecular targets modulated by this agent are transcription factors, growth factors and their receptors, cytokines, enzymes, and genes that regulate cell pro liferat ion and apoptosis. 3 Microspheres are one of the multipart iculate delivery systems and are prepared to obtain prolonged or controlled drug delivery, to improve bioavailab ility or stability and to target drug to specific sites. Microspheres can also offer advantages like limit ing fluctuation within therapeutic range, reducing side effects, decreasing dosing frequency and improving patient compliance.
MATERIALS AND METHODS:
Curcu min is a gift sample fro m Natural Remed ies , Bangalore. Eudragit S 100, Propan-1-o l and Chlorofo rm were also used in study. All the reagents and solvents used were of analytical grade satisfying pharmacopoeial standards.
Preparation of micros pheres
Curcu min microspheres were prepared by solvent evaporation technique 5 . Eudragit S 100 was dissolved in a mixtu re of Propan-1-ol and Chloroform (1:2) at room temperature. Curcu min was added to the above solution stirred in a magnetic stirrer to form a homogeneous solution. Then the above solution poured into 100ml of water containing 0.02% of Sodiu m laury l sulfate maintained at room temperature and stirred at 1000 rp m for 90 minutes, the resultant mixtures was filtered then wash with distilled water. The microspheres formed were then dried at room temperature. Three different formulat ions with different drug: polymer ratios (1:1, 1:2, 1:3) were prepared. 6 About 50mg of microspheres were weighed which was dissolved in Ethanol and made up to 100ml with distilled water shaken in mechanical shaker for 24h. Then solution
Encapsul ation efficiency of the microspheres

ABS TRACT:
The aim of this present investigation was to formulate and evaluate pH sensitive polymer coated micro particles containing Curcumin for colon targeting. pH sensitive polymer such as Eudragit S 100 were selected as a model encapsulation material. The micro particles were prepared by solvent evaporation technique using different ratio of curcumin and Eudragit (1:1to1:3). The prepared microspheres were subjected to various evaluation parameters such as angle of repose, drug loading, encapsulation efficiency, scanning electron microscopy, differential scanning colorimeter, in-vitro release studies, release kinetics and stability studies. Scanning electron microscopy revealed spherical nature and smooth surface morphology of the microspheres. The size of the microspheres was between 29.21-31.27µm. The encapsulation efficiency was between 21.73% -43.75 % and drug content was between 14.83% -18.36 %. The FT-IR and DSC thermograms confirmed the absence of drug polymer interaction. The micro particles prepared were filled in hard gelatin capsules which were enteric coated with cellulose acetate phthalate (CAP) which prevent the burst effect of capsule in acidic pH of stomach. The in vitro release study showed that there was no drug release in pH 1.2 acidic buffer, drug release was between 66.12% -71.87% for 10 hrs in phosphate buffer and controlled by Fickian diffusion mechanism. It is concluded from the present investigation that Eudragit microspheres are promising controlled release carriers for colon-targeted delivery of curcumin. Key words: Curcumin, eudragit S 100, solvent evaporation method, microspheres, pH dependent, colon targeting. 
Scanning electron microscope anal ysis
Shapes and surface characteristics of the microspheres were investigated and photographed using scanning electron microscope (SEM; JEOL JSM T -330A, Japan).
Particle size analysis
Measurements of the particle size d istribution of microspheres were carried out with an optical microscope.
Stage micro meter was used to calculate calibrat ion factor. The particle size was calculated by multiply ing the number of division of the ocular disc occupied by the particle with calibrat ion factor. Hundred randomly chosen spheres were taken to measure their indiv idual size.
Differential Scanning Calori metry
The physical state of Curcumin in the microspheres was analyzed by Differential Scanning Calorimeter (MettlerToledo star 822 e system, Swit zerland). The thermo grams of the Curcumin, physical mixture of Curcu min and polymer, and Curcu min microspheres were obtained at a scanning rate of 10°C/ min conducted over a temperature range of 170-250°C, respectively.
Drug polymer interacti on (FTIR) study
FTIR spectroscopy was performed on Fourier transform infrared spectrophotometer. The pellets of drug and potassium bro mide were prepared by compressing the powders at 20 psi for 3 min on KBr-press and the spectra were scanned in the wave number range of 4000-600 cm -1 . FT-IR study was carried on Curcumin, physical mixture of Curcu min, and Curcu min microspheres.
Coati ng of Hard Gelatin Capsules
7, 8
Hard gelat in capsules of 'size 0' were chosen for coating. The bodies and caps separated manually. Cu rcu min microspheres equivalent to 5 mg of curcumin were accurately weighed and filled into the bodies by hand filling and the cap was replaced. The enteric coating solution was prepared by using the formula which is given in table1. The capsules were co mp letely coated with 5% CAP by dip coating method. The capsules were alternatively dipped in 5% CAP solution and dried. Coating was repeated until an expected weight gain 8-12% was obtained and capsule resists disintegration in 0.1N HCl for minimu m of 2 hrs. Percentage weight gain of the capsules before and after coating was determined. Dissolution studies were carried out by using USP type II dissolution test apparatus by rotating basket method in stimulated gastric fluid pH 1.2 for 2 h, pH6.8 for 3 h and pH 7.4 for next 5 h. The dissolution media were maintained at a temperature of 37 ± 5 0 C. The speed of rotation of basket maintained was 100 rp m.
Enteric coated capsules which were previously filled with Curcu min microspheres were placed in basket in each dissolution vessel and covered with nylon cloth to prevent floating. 1 ml of dissolution media was withdrawn at predetermined time intervals and fresh dissolution media was replaced. The withdrawn samp les were analyzed and the amount of Curcumin released was determined by UV absorption spectroscopy at 427 n m.
RES ULTS AND DIS CUSSION:
Microspheres of Curcumin were prepared by solvent evaporation techniques by using polymer like Eudragit S 100. The prepared Curcu min microspheres were then subjected to FT-IR, SEM , part icle size, size d istribution, % yield, drug content, entrapment efficiency, in vitro dissolution, release kinetics, and DSC.
First, trials were made to prepare microspheres by using a solvent evaporation technique in the chloroform/ liquid paraffin system was used but no spherical particles could be obtained. Then water phase is used and various formulat ions with different polymer and drug ratios were tried, stirring speed was also changed to obtain spherical particles. These microsphere formulations are shown in table 2.
Loading efficiency of the drug depended on solubility of drug in solvents and continuous phase and physic chemical properties of drug and polymer 10 . High encapsulation efficiency was observed in different formulat ion of Curcu min Encapsulation efficiency is given in table: 3.
The mean particle size of Curcu min microspheres was in range of 29.21-31.27µm. As it was evident fro m the results that particle size increases as polymer concentration was increased. The data showing particle size analysis is given in table: 4. Fro m Scanning electron microscopy, it was observed that particles were spherical. The surface of the drug-loaded Eudragit S 100 microspheres shown in Figure: 1. Eudragit S 100 microspheres showed smooth surface. All the microspheres had small pores on their surfaces, which will be responsible for release.
Figure: 1 S EM i mages of Eudragit L 100micros pheres of Curcumin
Drug poly mer interaction can be studied by FT-IR analysis. Figure: 2 show the IR spectra of pure Curcu min, drug loaded microspheres and physical mixture. The same peaks were also reported in all drug loaded microspheres and in physical mixture. There was no change or shifting of characteristic peaks in drug loaded microspheres suggested that there was no significant drug poly mer interaction which indicates the stable nature of drug in all formulat ions.
Any possible drug polymer interaction can also be studied by thermal analysis. DSC studies were performed on pure drug and drug-loaded microspheres. DSC themograms of pure Curcumin (figure: 3) showed a sharp endothermic peak at 176.77°C. The themograms of formulation also showed a similar endothermic peak at 180.24°C. This further confirms that there is no drug poly mer interaction. The in-vitro release data was fitted to various kinetic models in order to find out the drug release mechanis m. The 'n' value obtained from Korsemeyer-Peppas equation for Eudragit L 100was in range of 0.365 to 0.371 suggested that the drug release from microspheres followed fickian d iffusion mechanism 12 .
CONCLUS ION:
The Curcu min loaded microspheres were prepared by solvent evaporation method using Eudragit S 100. Poly mer: drug ratio and stirring speed of the system were important to obtain spherical particles with smooth surfaces. The yields of preparation and encapsulation efficiencies were very high for all microspheres obtained. The prepared microspheres were free flowing and discrete. The FT-IR and DSC suggested no drug polymer interaction during encapsulation process. The drug release was studied up to 10 hours and results indicate that release of drug from microspheres followed fickian diffusion mechanis m.
